Prognostic role of dobutamine stress echocardiography in myocardial viability

Current Opinion in Cardiology

Volumn 21, Issue 5, 2006, Pages 443-449

  Schinkel, Arend F L ^a   Poldermans, Don ^a   Elhendy, Abdou ^b   Bax, Jeroen J ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary revascularization; Dobutamine stress echocardiography; Myocardial viability; Prognosis

Indexed keywords

DOBUTAMINE;

ACUTE HEART INFARCTION; CARDIOMYOPATHY; CONVALESCENCE; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; FUNCTIONAL RESIDUAL CAPACITY; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE;

CARDIOMYOPATHIES; ECHOCARDIOGRAPHY, STRESS; HEART; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; TISSUE SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33747051171     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000240580.82182.05     Document Type: Review

References (50)

1. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22 (4 Suppl A):6A-13A.
2. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004; 292:344-350.
3. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347:1397-1402.
4. Elefteriades JA, Tolis G Jr, Levi E, et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993; 22:1411-1417.
5. Baker DW, Jones R, Hodges J, et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994; 272:1528-1534.
6. Bax JJ, Poldermans D, Elhendy A, et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001; 26:141-186.
7. Schinkel AFL, Poldermans D, Vanoverschelde JL, et al. Incidence of recovery of contractile function following revascularization in patients with ischemic left ventricular dysfunction. Am J Cardiol 2004; 93:14-17.
8. Diamond GA, Forrester JS, deLuz PL, et al. Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 1978; 95:204-209.
9. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-221.
10. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72 (Suppl. V):V123-V135.
11. Wann LS, Faris JV, Childress RH, et al. Exercise cross-sectional echocardiography in ischemic heart disease. Circulation 1979; 60:1300-1308.
12. Poldermans D, Rambaldi R, Bax JJ, et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 1998; 19:1712-1718.
13. Picano E, Alaimo A, Chubuchny V, et al. Noninvasive pacemaker stress echocardiography for diagnosis of coronary artery disease: a multicenter study. J Am Coll Cardiol 2002; 40:1305-1310.
14. Biagini E, Schinkel AFL, Elhendy A, et al. Pacemaker stress echocardiography predicts cardiac events in patients with permanent pacemaker. Am J Med 2005; 118:1381-1386. Prognostic study evaluating the role of pacemaker stress echocardiography in 140 patients with a permanent right ventricular pacemaker.
15. Sozzi FB, Poldermans D, Bax JJ, et al. Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography. Heart 2001; 86:672-678.
16. Tsutsui JM, Elhendy A, Anderson JR, et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005; 112:1444-1450. This study demonstrates the excellent prognostic value of real-time contrast echocardiography in conjunction with dobutamine stress in the risk stratification of patients with known or suspected coronary artery disease.
17. Rambaldi R, Poldermans D, Bax JJ, et al. Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 2000; 21:1091-1098.
18. Bountioukos M, Schinkel AFL, Bax JJ, et al. Pulsed-wave tissue Doppler quantification of systolic and diastolic function of viable and nonviable myocardium in patients with ischemic cardiomyopathy. Am Heart J 2004; 148:1079-1084.
19. Hanekom L, Jenkins C, Jeffries L, et al. Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization. Circulation 2005; 112:3892-3900. Study demonstrating that the measurement of strain rate during low-dose dobutamine stress echocardiography is feasible, and improves the sensitivity of viability assessment.
20. Carlos ME, Smart SC, Wynsen JC, Sagar KB. Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997; 95:1402-1410.
21. Sicari R, Picano E, Landi P, et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study. J Am Coll Cardiol 1997; 29:254-260.
22. Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998; 98:1078-1084.
23. Previtali M, Fetiveau R, Lanzarini L, et al. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis. J Am Coll Cardiol 1998; 32:380-386.
24. Bigi R, Desideri A, Bax JJ, et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol 2001; 87:283-288.
25. Nijland F, Kamp O, Verhorst PM, et al. In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction. Am J Cardiol 2001; 88:949-955.
26. Swinburn JM, Senior R. Myocardial viability assessed by dobutamine stress echocardiography predicts reduced mortality early after acute myocardial infarction: determining the risk of events after myocardial infarction (DREAM) study. Heart 2006; 92:44-48. Dobutamine stress echocardiography proved to be a powerful predictor of outcome in 212 stable survivors of acute myocardial infarction, whereas the presence of myocardial viability had a positive impact on survival.
27. Schinkel AFL, Bax JJ, van Domburg R, et al. Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy. J Nucl Med 2003; 44:127-133.
28. Beller GA. Assessment of myocardial viability. Curr Opinion Cardiol 1997; 12:459-467.
29. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med 1998; 339:173-181.
30. Schinkel AFL, Poldermans D, Rizzello V, et al. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg 2004; 127:385-390.
31. Bax JJ, Schinkel AFL, Boersma E, et al. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004; 110 (Suppl 1):II18-II22.
32. Rizzello V, Poldermans D, Boersma E, et al. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 2004; 110:2383-2388.
33. Williams MJ, Odabashian J, Lauer MS, et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996; 27:132-139.
34. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998; 32:912-920.
35. Afridi I, Grayburn PA, Panza JA, et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998; 32:921-926.
36. Anselmi M, Golia G, Cicoira M, et al. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 1998; 81:21G-28G.
37. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999; 33:1848-1854.
38. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999; 34:163-169.
39. Chaudhry FA, Tauke JT, Alessandrini RS, et al. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999; 34:730-738.
40. Meluzin J, Cerny J, Spinarova L, et al. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability. Eur J Heart Fail 2003; 5:85-93.
41. Sicari R, Picano E, Cortigiani L, et al., VIDA (Viability Identification with Dobutamine Administration) Study Group. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 2003; 92:1263-1266.
42. Rambaldi R, Bax JJ, Rizzello V, et al. Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction. Coron Artery Dis 2005; 16:141-145.
43. Rizzello V, Poldermans D, Schinkel AFL, et al. Long-term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 2006; 92:239-244.
44. Biagini E, Galema TW, Schinkel AFL, et al. Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2004; 43:1489-1493.
45. Cwajg JM, Cwajg E, Nagueh SF, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation: relation to rest-redistribution Tl-201 tomography and dobutamine stress echocardiography. J Am Coll Cardiol 2000; 35:1152-1161.
46. Schinkel AFL, Bax JJ, Boersma E, et al. Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction. Am Heart J 2002; 144:865-869.
47. Schinkel AFL, Bax JJ, Boersma E, et al. How many patients with ischemic cardiomyopathy exhibit viable myocardium? Am J Cardiol 2001; 88:561-564.
48. Rizzello V, Schinkel AFL, Bax JJ, et al. Individual prediction of functional recovery after coronary revascularization in patients with ischemic cardiomyopathy: the scar-to-biphasic model. Am J Cardiol 2003; 91:1406-1409.
49. Smart SC, Dionisopoulos PN, Knickelbine TA, et al. Dobutamine-atropine stress echocardiography for risk stratification in patients with chronic left ventricular dysfunction. J Am Coll Cardiol 1999; 33:512-521.
50. Sawada S, Bapat A, Vaz D, et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 2003; 42:2099-2105.